| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000025752 |
| Receipt No. | R000029625 |
| Official scientific title of the study | Biochemical analysis of tear composition in dry eye patients |
| Date of disclosure of the study information | 2017/01/20 |
| Last modified on | 2017/01/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Biochemical analysis of tear composition in dry eye patients | |
| Title of the study (Brief title) | Biochemical analysis of tear composition | |
| Region |
|
|
| Condition | ||
| Condition | Dry eye | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To analyze the tear compostion, including tear proteins and lipids, in patients with dry eye |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the composition which plays a role in pathophysiology of dry eye, which may lead to future treatment. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Tears are colloected by Schirmer test strips from the dry eye patints, which are clinically performed. After the elution of tear protein and lipid, total protein and lactoferrinm lipocalin, lysozyme and secretory IgA are measured. And cytokines, phospholipase A2, lipids are fractioned and quantified. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Dry eye patients
(defined by the diagnostic criteria of Japan dry eye society 2006) |
|||
| Key exclusion criteria | 1) Complication of anterior disease(blepharitis, lagophthalmos, blepharospasm and iritis) other than dry eye ( patients with past history of the above disease are included).
2) Patients who were assessed as inadequate. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Masakazu Yamada |
| Organization | National Hospital Organization Tokyo Medical Center |
| Division name | Division for Vision Research, National Institute of Sensory Organs |
| Address | 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8982 Japan |
| TEL | 03-3411-0379 |
| yamada@eye-center.org | |
| Public contact | |
| Name of contact person | Chika Shigeyasu |
| Organization | National Hospital Organization Tokyo Medical Center |
| Division name | Division for Vision Research, National Institute of Sensory Organs |
| Address | 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8982 Japan |
| TEL | 03-3411-0379 |
| Homepage URL | |
| shigeyasu@kankakuki.go.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology, National Hospital Organization Tokyo Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Ophthalmology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | It is a study using Schirmer test, which is normally performed in dry eye patients. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029625 |